These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9796767)
1. Hormonal therapy in the management of premenstrual syndrome. Tiemstra JD; Patel K J Am Board Fam Pract; 1998; 11(5):378-81. PubMed ID: 9796767 [TBL] [Abstract][Full Text] [Related]
2. Hormonal management of premenstrual syndrome. Usman SB; Indusekhar R; O'Brien S Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457 [TBL] [Abstract][Full Text] [Related]
3. Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial. Shehata NAA; Moety GAFA; El Wahed HAA; Fahim AS; Katta MA; Hussein GK Reprod Sci; 2020 Feb; 27(2):743-750. PubMed ID: 32046452 [TBL] [Abstract][Full Text] [Related]
4. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice]. Svojanovská K Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928 [TBL] [Abstract][Full Text] [Related]
5. Premenstrual syndrome: A mini review. Ryu A; Kim TH Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143 [TBL] [Abstract][Full Text] [Related]
6. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. Graham CA; Sherwin BB J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Rapkin AJ; Akopians AL Menopause Int; 2012 Jun; 18(2):52-9. PubMed ID: 22611222 [TBL] [Abstract][Full Text] [Related]
8. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Rapkin A Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():39-53. PubMed ID: 12892989 [TBL] [Abstract][Full Text] [Related]
13. Premenstrual syndrome and migraine. Allais G; Castagnoli Gabellari I; Burzio C; Rolando S; De Lorenzo C; Mana O; Benedetto C Neurol Sci; 2012 May; 33 Suppl 1():S111-5. PubMed ID: 22644184 [TBL] [Abstract][Full Text] [Related]
14. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
15. Norethisterone enantate in the treatment of premenstrual syndrome. Gunston KD S Afr Med J; 1995 Sep; 85(9):851-2. PubMed ID: 8545742 [TBL] [Abstract][Full Text] [Related]
16. Recording and treatment of premenstrual syndrome in UK general practice: a retrospective cohort study. Sammon CJ; Nazareth I; Petersen I BMJ Open; 2016 Mar; 6(3):e010244. PubMed ID: 26993623 [TBL] [Abstract][Full Text] [Related]
17. Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives. Coffee AL; Kuehl TJ; Sulak PJ Pharmacotherapy; 2008 May; 28(5):576-83. PubMed ID: 18447656 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M; J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453 [TBL] [Abstract][Full Text] [Related]
19. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Shulman LP Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825 [TBL] [Abstract][Full Text] [Related]